MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3

Genetics and Molecular Research

Volumn 12, Issue 2, 2013, Pages 1012-1021

  He, L ^a,b   Yao, H ^b   Fan, L H ^b   Liu, L ^b   Qiu, S ^b   Li, X ^b   Gao, J P ^a   Hao, C Q ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Invasion; miR 181b; PC 3; Proliferation; Prostate cancer

Indexed keywords

MICRORNA; MICRORNA 181B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CELL PROLIFERATION; CELL STRAIN PC 3; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PROSTATE CANCER; PROSTATE SURGERY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

EID: 84876243049     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.April.2.17     Document Type: Article

References (24)

1. Ambros V and Chen X (2007). The regulation of genes and genomes by small RNAs. Development 134: 1635-1641.
2. Berezikov E, Guryev V, van de Belt J, Wienholds E, et al. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
3. Chen C, Ridzon DA, Broomer AJ, Zhou Z, et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33: e179.
4. Chen H, Chen Q, Fang M and Mi Y (2009). Regulatory effect on the proliferation of the leukemic cell HL-60 by miRNA-181b through MLK2 science in China. Life Sci. 39: 1034-1040.
5. de Yébenes VG, Belver L, Pisano DG, Gonzalez S, et al. (2008). miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206.
6. Debernardi S, Skoulakis S, Molloy G, Chaplin T, et al. (2007). MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916.
7. Gibson W, Green A, Bullard RS, Eaddy AC, et al. (2007). Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. Cancer Lett. 248: 251-261.
8. Jonler M and Pedersen KV (2007). Diagnosis, evaluation and follow-up of patients with prostatic cancer. Ugeskr. Laeger 169: 1889-1891.
9. Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods 25: 402-408.
10. Marcucci G, Radmacher MD, Maharry K, Mrózek K, et al. (2008). MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358: 1919-1928.
11. Meltzer PS (2005). Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
12. Nakajima G, Hayashi K, Xi Y, Kudo K, et al. (2006). Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3: 317-324.
13. Ozen M, Creighton CJ, Ozdemir M and Ittmann M (2008). Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793.
14. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66: 11590-11593.
15. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, et al. (2007). MicroRNA expression profiling in prostate cancer. Cancer Res. 67: 6130-6135.
16. Prueitt RL, Yi M, Hudson RS, Wallace TA, et al. (2008). Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68: 1152-1164.
17. Rajewsky N (2006). microRNA target predictions in animals. Nat. Genet. 38 Suppl: S8-13.
18. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, et al. (2010). Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126: 1166-1176.
19. Shi L, Cheng Z, Zhang J, Li R, et al. (2008). hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236: 185-193.
20. Spahn M, Kneitz S, Scholz CJ, Stenger N, et al. (2010). Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int. J. Cancer 127: 394-403.
21. Stark A, Brennecke J, Bushati N, Russell RB, et al. (2005). Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146.
22. Volinia S, Calin GA, Liu CG, Ambs S, et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261.
23. Xu L and Wang GM (2007). The progress and current situation in the management of moderate and far advanced prostate cancer. Int. J. Urol. Nephrol. 27: 773.
24. Zhang B and Farwell MA (2008). microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J. Cell Mol. Med. 12: 3-21.